Trending stocks today
Moderna (MRNA-Q)
NASDAQ:MRNA
41.51
4.14
(9.07%) 1d
Financials
Technical Analysis
Buy, Sell or Hold?
This summary was created by AI, based on 10 opinions in the last 12 months.
The expert reviews on Moderna (MRNA-Q) are mixed, with some expressing concerns about the company's performance and financial losses, while others see potential in its technology and leadership. The stock has experienced significant fluctuations and volatility in the market, with both positive and negative developments affecting its performance. The company's ability to deliver on its promises, such as cancer vaccines and leveraging AI, remains a point of contention among the experts. Overall, the outlook for Moderna appears uncertain, and investors may need to carefully consider the risk and potential of this stock.
$54.630
Unknown
They should have done something with the money they had, and are now losing money hand over fist.
Down 33% the past month and could fall more. It isn't making any money and isn't delivering cancer vaccines.
They aren't producing the personalized cancer vaccines he expected, nor using AI as he hoped.
Moderna rallied 29% in May after a good report and news on developing a bird flu vaccine to fight that epidemic. Another boost came when the government approved their RSV vaccine. But Moderna is expected to lose money in the foreseeable future. Instead, look at biopharma.
It's had a huge price surge recently and is now too pricey. Prefers Pfizer.
A staple, and that sector is starting to outperform the market. A value play. His target is around $200-ish, if it can break resistance around $140. If it fails, give it a few days, and then walk away if you have to.
They have special technology; this morning they announced a collaboration with AI. Shares have been declining and there are sellers everywhere. You have to wait until they invent the special vaccines en masse they promised.
Believes in the CEO and their technology. Buy below $100.
Down 44% in 2023. They made the first Covid vaccine and made a ton of sales, but they suffer losses now. It didn't pull off a cancer vaccine as some hoped for. But it's up 9% in the past week. Maybe there's hope.
Covid vaccine was its first commercial product, and it did well. That's trailing off. Investing in drug pipeline, and it's hard to determine when products might be approved and launched. Her preference is a more established company with a pipeline.
A good mix of consumer goods and healthcare, but the PE is extended. Prefers to buy Pfizer for its growth and lower PE. He might even roll the dice with Moderna. Or buy the IBB, biotech ETF.
Down 26% in the last 23 months. It's suffering a post-Covid hangover and the company is better than this.
Moderna(MRNA-Q) Rating
Ranking : 3 out of 5
Bullish - Buy Signals / Votes : 1
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 7
Total Signals / Votes : 8
Moderna(MRNA-Q) Frequently Asked Questions
What is Moderna stock symbol?
Moderna is a American stock, trading under the symbol MRNA-Q on the NASDAQ (MRNA). It is usually referred to as NASDAQ:MRNA or MRNA-Q
Is Moderna a buy or a sell?
In the last year, 8 stock analysts published opinions about MRNA-Q. 1 analyst recommended to BUY the stock. 7 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Moderna.
Is Moderna a good investment or a top pick?
Moderna was recommended as a Top Pick by on . Read the latest stock experts ratings for Moderna.
Why is Moderna stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Moderna worth watching?
8 stock analysts on Stockchase covered Moderna In the last year. It is a trending stock that is worth watching.
What is Moderna stock price?
On 2024-12-10, Moderna (MRNA-Q) stock closed at a price of $41.51.
They aren't delivering on the things--vaccine results--they promise. He struggles with this stock.